Previous 10 | Next 10 |
ESSA Pharma Announces $36 Million Public Offering of Common Stock and Concurrent Private Placement Canada NewsWire VANCOUVER and HOUSTON, Aug. 23, 2019 VANCOUVER and HOUSTON , Aug. 23, 2019 /CNW/ - ESSA Pharma Inc. (NASDAQ: EPIX; TSXV: EPI) (" ESSA " or the " Company ")...
ESSA Pharma (NASDAQ: EPIX ): Q3 Non-GAAP EPS of -$0.52. More news on: ESSA Pharma Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2019 Canada NewsWire VANCOUVER and HOUSTON, Aug. 14, 2019 VANCOUVER and HOUSTON , Aug. 14, 2019 /CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (TSX-V: EPI, N...
Merger activity decreased last week with three new deals announced and ten pending deals closing. Deal Statistics: New Deals: The acquisition of Genomic Health ([[GHDX]]) by Exact Sciences Corporation ([[EXAS]]) for $2.8 billion in a cash-plus-stock deal. Under the terms of the ...
ESSA Announces that the Scheme of Arrangement with Realm Therapeutics has become Effective Canada NewsWire VANCOUVER and HOUSTON, July 31, 2019 VANCOUVER and HOUSTON , July 31, 2019 /CNW/ - ESSA Pharma Inc. (" ESSA " or the "Company ") (NASDAQ: EPIX; TSX-V: EPI), a pha...
VANCOUVER and HOUSTON, TX , July 30, 2019 /PRNewswire/ - ESSA Pharma Inc. (" ESSA " or "the Company ") (NASDAQ: EPIX; TSX-V: EPI), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, is pleased to announce that, further to the annou...
VANCOUVER and HOUSTON , July 15, 2019 /PRNewswire/ - ESSA Pharma Inc. (" ESSA " or "the Company ") (NASDAQ: EPIX; TSX-V: EPI), a pharmaceutical company focused on the developing novel therapies for the treatment of prostate cancer, announced today the appointment of Dr. Alessandra Ces...
Chiyoda ( CHYCF ) reassignment Chiyoda (6366 JP), a global (based in Japan) engineering company, which specializes in oil and gas midstream for LNG and gas processing, has announced a reassignment to another sector of Tokyo Stock exchange. This might present an interesting short opportun...
VANCOUVER and HOUSTON , July 8, 2019 /PRNewswire/ - ESSA Pharma Inc. (" ESSA " or "the Company ") (NASDAQ: EPIX; TSX-V: EPI), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, announces that the hearing at the High Court of Justice in ...
HOUSTON and VANCOUVER , June 26, 2019 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") (Nasdaq: EPIX; TSX-V: EPI), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer provides an update, further to the announcement made on May 16...
News, Short Squeeze, Breakout and More Instantly...
ESSA Pharma to Present at the JonesHealthcare Seaside Summit Canada NewsWire SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC , July 8, 2024 /CNW/ - ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on de...
ESSA Pharma to Present at the Jefferies Global Healthcare Conference Canada NewsWire SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC , May 30, 2024 /CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focus...